OpGen Acquires Curetis N.V.

Curetis is a molecular diagnostics company that focuses on the development and commercialization of reliable, fast and cost-effective syndromic testing products for the diagnosis of severe infectious diseases. The diagnostic solution Unyvero of Curetis enables rapid multi-parameter pathogen and antibiotic resistance marker detection in only a few hours, a process that today can take up to days or even weeks with other techniques. Curetis was formed in 2007 and is based in Holzgerlingen, Germany.